NFI announces first quarter 2024 results
May 02, 2024 16:30 ET
|
NFI Group Inc
All figures quoted in U.S. dollars unless otherwise noted: 2024 Q1 revenue of $723 million; 1,127 equivalent units ("EUs") delivered, up 42% from 2023 Q1, with 201 of EUs delivered being...
CTO Realty Growth Reports First Quarter 2024 Operating Results
May 02, 2024 16:10 ET
|
CTO Realty Growth, Inc.
WINTER PARK, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced its operating results and earnings for the quarter ended March 31,...
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024 16:10 ET
|
Quoin Pharmaceuticals, Inc.
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan...
LeMaitre Q1 2024 Financial Results
May 02, 2024 16:05 ET
|
LeMaitre Vascular, Inc.
BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly...
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
May 02, 2024 16:05 ET
|
Cardiff Oncology, Inc.
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated...
Kura Oncology Reports First Quarter 2024 Financial Results
May 02, 2024 16:05 ET
|
Kura Oncology, Inc.
– Breakthrough Therapy Designation for ziftomenib in NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track to complete enrollment by mid-2024 – – Positive...
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
May 02, 2024 16:03 ET
|
EMCORE Corporation
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
Gevo Reports First Quarter 2024 Financial Results
May 02, 2024 16:01 ET
|
Gevo, Inc.
ENGLEWOOD, Colo., May 02, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the first quarter 2024 and recent...
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma announces first quarter 2024 results and provides corporate update
Complete Solaria to be Self-Funded in Q2 2024
May 02, 2024 14:30 ET
|
Complete Solaria Inc.
Complete Solaria reported earnings today and announced the Company will be self-funded in Q2 2024.